Cellectis S.A. (EPA:ALCLS)
1.238
-0.113 (-8.36%)
Nov 12, 2026, 9:24 AM CET
Cellectis Employees
As of December 31, 2025, Cellectis had 229 total employees, including 224 full-time and 5 part-time employees. The number of employees increased by 7 or 3.15% compared to the previous year. That makes Cellectis the 25,815th largest employer in the world and 321st in France.
Employees
229
Change (1Y)
7
Growth (1Y)
3.15%
Revenue / Employee
€246,098
Profits / Employee
€251,847
Market Cap
90.00M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 229 | 7 | 3.15% | 224 | 5 |
| Dec 31, 2024 | 222 | 1 | 0.45% | 216 | 6 |
| Dec 31, 2023 | 221 | -16 | -6.75% | 216 | 5 |
| Dec 31, 2022 | 237 | -63 | -21.00% | 231 | 6 |
| Dec 31, 2021 | 300 | 19 | 6.76% | 294 | 6 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Transgene | 152 |
| Innate Pharma | 120 |
| Adocia | 80 |
| Sensorion | 66 |
| OSE Immunotherapeutics | 64 |
| Fermentalg | 62 |
| MaaT Pharma | 60 |
| ABIONYX Pharma | 49 |
Cellectis News
- 2 days ago - Cellectis to Report Third Quarter Financial Results on November 12, 2026 - GlobeNewsWire
- 14 days ago - Cellectis S.A. Presents Preclinical Data Highlighting Efficient APOC3 Editing and Marked Triglyceride Reduction with .HEAL-101 at ESGCT 2026 - Nasdaq
- 14 days ago - Cellectis' .HEAL-101 Lowers Triglycerides In Preclinical Study; Phase 1 Data Expected In H2'27 - Nasdaq
- 16 days ago - Cellectis Presents Preclinical Data Highlighting Efficient APOC3 Editing and Marked Triglyceride Reduction with .HEAL-101 at ESGCT 2026 - GlobeNewsWire
- 20 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. - CLLS - PRNewsWire
- 22 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. – CLLS - GlobeNewsWire
- 27 days ago - Securities Fraud Investigation Into Cellectis S.A. (CLLS) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - GlobeNewsWire
- 27 days ago - Cellectis S.A. (CLLS) Shareholders Who Lost Money – Contact Law Offices of Howard G. - GlobeNewsWire